Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes | Zendy

David Nanchen | Zendy; Bariş Gencer | Zendy; Olivier Müller | Zendy; Reto Auer | Zendy; Soheila Aghlmandi | Zendy; Dik Heg | Zendy; Roland Klingenberg | Zendy; Lorenz Räber | Zendy; David Carballo | Zendy; Sebastian Carballo | Zendy; Christian M. Matter | Zendy; Thomas F. Lüscher | Zendy; Stephan Windecker | Zendy; François Mach | Zendy; Nicolas Rodondi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes

Author(s) -

David Nanchen,

Bariş Gencer,

Olivier Müller,

Reto Auer,

Soheila Aghlmandi,

Dik Heg,

Roland Klingenberg,

Lorenz Räber,

David Carballo,

Sebastian Carballo,

Christian M. Matter,

Thomas F. Lüscher,

Stephan Windecker,

François Mach,

Nicolas Rodondi

Publication year - 2016

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.116.023007

Subject(s) - medicine , myocardial infarction , acute coronary syndrome , cardiology , diabetes mellitus , familial hypercholesterolemia , cohort , coronary artery disease , statin , prospective cohort study , body mass index , cholesterol , endocrinology

Patients with heterozygous familial hypercholesterolemia (FH) and coronary heart disease have high mortality rates. However, in an era of high-dose statin prescription after acute coronary syndrome (ACS), the risk of recurrent coronary and cardiovascular events associated with FH might be mitigated. We compared coronary event rates between patients with and without FH after ACS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research